Innovation in bone healing and tissue repair

Sealants provide rapid and reliable closure of tissue membranes to ensure functional integrity after surgery or trauma.

Kuros uses a synthetic matrix technology which combines ease of administration with reliable and pressure resistant, rapid closure of the damaged tissues. Kuros' lead sealant product is Neuroseal (KUR-023) developed as an adjunct to suturing for sealing of the dura after cranial surgery. The program has demonstrated its clinical utility in an EU clinical trial and is currently under review for CE certification as a Class III medical device.

Surgical sealants are used in many surgical procedures where leakage of body fluids or gases have to be minimized. Examples of such uses are the sealing of blood vessels, the gastrointestinal tract, lobes of the lung or of the dura mater surrounding the brain and spinal cord.

Kuros’ technology can be tailored to optimally address the specific needs of a given indication. The most advanced sealant product candidate is designed to address the dural sealant market.

Projections of the medical adhesives and sealant market in the US predict it to reach USD 2.3 billion per annum by 2017 (Global Industry Analysts, Inc, 2012).

 

Kuros Biosciences AG
Wagistrasse 25, 8952 Schlieren, Switzerland
Tel: +41 (0)44 200 56 00   Fax: +41 (0)44 200 56 01   Email: info@kuros.ch

About Kuros

  1. Overview
  2. Management
  3. Board

Products

  1. Pipeline
  2. Orthobiologics
    Fracture repair
    KUR-111
    KUR-113
    Spinal fusion
    KUR-113
    Solitary Bone Cysts
    KUR-112
  3. Sealants
    Neuroseal (KUR-023)

Technologies

  1. Overview
  2. Fibrin-based
  3. Synthetic-based
  4. Immune modulation
  5. Publications

Partnerships

  1. Collaborations
  2. Business development

Investors

  1. Share price
  2. Regulatory filings
  3. Reports & presentations
  4. Calendar
  5. Corporate governance
  6. Stay informed

News

  1. Press releases
  2. Conferences & Events

Contact

  1. Location
Sealants

Sealants provide rapid and reliable closure of tissue membranes to ensure functional integrity after surgery or trauma.

Kuros uses a synthetic matrix technology which combines ease of administration with reliable and pressure resistant, rapid closure of the damaged tissues. Kuros' lead sealant product is Neuroseal (KUR-023) developed as an adjunct to suturing for sealing of the dura after cranial surgery. The program has demonstrated its clinical utility in an EU clinical trial and is currently under review for CE certification as a Class III medical device.

Surgical sealants are used in many surgical procedures where leakage of body fluids or gases have to be minimized. Examples of such uses are the sealing of blood vessels, the gastrointestinal tract, lobes of the lung or of the dura mater surrounding the brain and spinal cord.

Kuros’ technology can be tailored to optimally address the specific needs of a given indication. The most advanced sealant product candidate is designed to address the dural sealant market.

Projections of the medical adhesives and sealant market in the US predict it to reach USD 2.3 billion per annum by 2017 (Global Industry Analysts, Inc, 2012).